Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-24

Clinical Trial Update: Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial comparing blinded buprenorphine vs morphine for neonatal abstinence syndrome has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Morphine (morphine)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Neonatal Abstinence Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2020-03-24